Health & Biotech
Health & Biotech
Althea becomes first local cannabis player to launch online sales channel
Health & Biotech
Victoria’s lockdown helps Global Health win new business, shares rise 60pc+
Health & Biotech
Fresh off US success, LBT moves on Europe
Health & Biotech
Allegra rockets 500pc+ after taking ownership of synthetic bone substitute IP
Health & Biotech
Greg Hunt revives one-stop-shop idea for Aussie clinical trials
Health & Biotech
Nyrada one step closer to cholesterol pill, shares surge
Health & Biotech
The watchlist of likely losers from Victoria re-entering lockdown
Health & Biotech
Dr Boreham’s Crucible: Mesoblast within months of 3 major trial results, key regulatory decision
Health & Biotech
MGC Pharma selected for WHO COVID taskforce, shares jump
Health & Biotech
Osteopore cracks billion dollar US bone healing market, shares surge
Health & Biotech
Bod makes $2.5m from Aussie pot buyers in the June quarter alone
Health & Biotech
Strong interest for Compass Cannabis’ $2m cap raise kick-off
Health & Biotech
MedAdvisor eyes off US health insurance market with new distribution deal
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
Health & Biotech
The elective surgery stocks getting a boost from the easing of COVID-19 restrictions
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.